These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30790279)

  • 1. Resolution of acenocoumarol-associated calciphylaxis with drug withdrawal.
    Suárez-Peñaranda JM; Minasyan A; Sainz-Gaspar L; Sánchez-Aguilar MD
    Australas J Dermatol; 2019 Aug; 60(3):e223-e226. PubMed ID: 30790279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical calciphylaxis secondary to treatment with acenocoumarol.
    Alvarez-Pérez A; Gutiérrez-González E; Sánchez-Aguilar D; Toribio J
    Actas Dermosifiliogr; 2012 Jan; 103(1):79-81. PubMed ID: 22444506
    [No Abstract]   [Full Text] [Related]  

  • 3. Acenocoumarol as a risk factor for calciphylaxis: a feature clinicians should be aware of.
    Wenstedt EFE; Huysentruyt CJ; Konings CJAM
    Neth J Med; 2017 May; 75(4):161-164. PubMed ID: 28522774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-uremic calciphylaxis due to acenocoumarol].
    Torres-Bondia FI; Parada-Saavedra FJ; Fernández-Armenteros JM; Schoenenberger-Arnaiz JA
    Farm Hosp; 2017 Jul; 41(4):569-570. PubMed ID: 28683713
    [No Abstract]   [Full Text] [Related]  

  • 5. [Atypical calciphylaxis secondary to treatment with acenocoumarol].
    Alvarez-Pérez A; Gutiérrez-González E; Sánchez-Aguilar D; Toribio J
    Actas Dermosifiliogr; 2012; 103(1):79-81. PubMed ID: 22000587
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sodium thiosulfate for the treatment of acenocumarol-induced calciphylaxis in a patient with preserved kidney function].
    Mateos Egido E; Álamo Medina A; Ródenas Gálvez AC; Lombardero Pin M; Díez Del Pino A
    Farm Hosp; 2017 May; 41(3):425-427. PubMed ID: 28478757
    [No Abstract]   [Full Text] [Related]  

  • 7. Acenocoumarol and vasculitis: a case report.
    Aouam K; Gassab A; Khorchani H; Bel Hadj Ali H; Amri M; Boughattas NA; Zili JE
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):113-4. PubMed ID: 16981216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-uremic Calciphylaxis: A Rare and Late Adverse Reaction of Warfarin.
    Patel DM; Patel MV; Patel AD; Kaklotar JC; Patel GR; Patel MM
    Curr Drug Saf; 2019; 14(3):246-248. PubMed ID: 30834840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical calciphylaxis in a patient receiving warfarin then resolving with cessation of warfarin and application of hyperbaric oxygen therapy.
    Banerjee C; Woller SC; Holm JR; Stevens SM; Lahey MJ
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):345-50. PubMed ID: 20019019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin-induced calciphylaxis.
    Al-ani M; Parperis K
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26783010
    [No Abstract]   [Full Text] [Related]  

  • 11. Strokes soon after oral anticoagulant therapy in patients with atrial fibrillation.
    De Keyser J; Herroelen L
    Lancet; 1991 Nov; 338(8775):1158. PubMed ID: 1682588
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacogenetics role in the safety of acenocoumarol therapy.
    Jiménez-Varo E; Cañadas-Garre M; Henriques CI; Pinheiro AM; Gutiérrez-Pimentel MJ; Calleja-Hernández MÁ
    Thromb Haemost; 2014 Sep; 112(3):522-36. PubMed ID: 24919870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of quality and hemorragic risk of oral anticoagulant therapy using acenocoumarol versus warfarin].
    Oliva Berini E; Galán Alvarez P; Pacheco Onrubia AM
    Med Clin (Barc); 2008 Jun; 131(3):96-7. PubMed ID: 18590623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acenocoumarol-induced Henoch-Schönlein purpura.
    Borrás-Blasco J; Girona E; Navarro-Ruiz A; Matarredona J; Giménez ME; Gutiérrez A; Enriquez R; Martinez A
    Ann Pharmacother; 2004 Feb; 38(2):261-4. PubMed ID: 14742763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of unstable anticoagulation with acenocoumarol versus warfarin in atrial fibrillation.
    Bryk AH; Plens K; Undas A
    Cardiol J; 2017; 24(5):477-483. PubMed ID: 28353307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality.
    Rivera-Caravaca JM; Marín F; Esteve-Pastor MA; Valdés M; Vicente V; Roldán V; Lip GYH
    Int J Clin Pract; 2018 Mar; 72(3):e13069. PubMed ID: 29436121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acenocoumarol: A Review of Anticoagulant Efficacy and Safety.
    Trailokya A; Hiremath JS; Sawhney J; Mishra YK; Kanhere V; Srinivasa R; Tiwaskar M
    J Assoc Physicians India; 2016 Feb; 64(2):88-93. PubMed ID: 27730796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients.
    Esteve-Pastor MA; Rivera-Caravaca JM; Roldán V; Vicente V; Romiti GF; Romanazzi I; Proietti M; Valdés M; Marín F; Lip GYH
    Int J Cardiol; 2018 Mar; 254():125-131. PubMed ID: 29248163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calciphylaxis treated with sodium thiosulfate: report of two cases.
    Garcia CP; Roson E; Peon G; Abalde MT; De La Torre C
    Dermatol Online J; 2013 Sep; 19(9):19616. PubMed ID: 24050290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Increased INR from concomitant use of acenocoumarol and capecitabine].
    Tomlow B; Voll ML; Smorenburg CH
    Ned Tijdschr Geneeskd; 2012; 156(26):A4793. PubMed ID: 22759711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.